PRKN and metabolic dysfunction-associated steatotic liver disease: Inhibition of Parkin- and PTEN-induced putative kinase 1 (PINK1)-mediated mitophagy exacerbates hepatic lipogenesis, inflammation, and insulin resistance in NAFLD mice, and upregulation of mitophagy levels effectively ameliorates hepatic steatosis in NAFLD mice (Chen et al., 2023).